Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02219087 · ClinicalTrials.gov registry record · NA

Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery

A NA study, sponsored by OhioHealth.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT02219087: Completed NA study, sponsored by OhioHealth.

NCT02219087 is a NA study that has completed, run by OhioHealth. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02219087, a NA study, has completed, sponsored by OhioHealth.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether liposomal bupivacaine is effective in the management of pain following total knee arthroplasty, as compared to standard of care analgesia.

Primary Outcome

Number of physical therapy (PT) sessions necessary for discharge. A significant decrease in the number of sessions will be defined as ≥ 2. Typically, there are 2 sessions per day, with each patient completing an average of 4-5 sessions during their admission.

Interventions

  • DRUG Standard of Care
  • DRUG Liposomal bupivacaine

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2014-08
Est. Completion 2016-03
Phase NA
OhioHealth

20 total trials

What the finished NCT02219087 record still lists

NCT02219087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.

NCT02219087 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02219087 about?

NCT02219087 is a clinical study titled "Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery". The purpose of this study is to determine whether liposomal bupivacaine is effective in the management of pain following total knee arthroplasty, as compared to standard of care analgesia.

What is the current status of trial NCT02219087?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2014-08. Estimated completion is 2016-03.

What interventions are being tested in trial NCT02219087?

The interventions under investigation include: Standard of Care (DRUG), Liposomal bupivacaine (DRUG).

Who is sponsoring clinical trial NCT02219087?

This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02219087's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02219087, the US trial registry maintained by the National Library of Medicine. NCT02219087 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.